tiprankstipranks
Elevation Oncology (ELEV)
NASDAQ:ELEV
US Market

Elevation Oncology (ELEV) Technical Analysis

Compare
556 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Elevation Oncology’s (ELEV) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Elevation Oncology is a Sell.
Elevation Oncology’s (ELEV) 20-Day exponential moving average is 0.65, while Elevation Oncology’s (ELEV) share price is $0.65, making it a Sell.
Elevation Oncology’s (ELEV) 50-Day exponential moving average is 0.66, while Elevation Oncology’s (ELEV) share price is $0.65, making it a Sell.

Elevation Oncology (ELEV) Pivot Points

Feb 20, 2025, 11:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.55
0.59
0.64
0.68
0.72
0.76
0.81
Fibonacci
0.59
0.63
0.65
0.68
0.71
0.73
0.76
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Elevation Oncology (ELEV) Moving Averages

Feb 20, 2025, 11:52 PM
Period
Simple
Exponential
MA5
0.66Sell
0.66Sell
MA10
0.65Buy
0.65Sell
MA20
0.65Buy
0.65Sell
MA50
0.66Sell
0.66Sell
MA100
0.62Buy
0.83Sell
MA200
1.45Sell
1.70Sell
Elevation Oncology’s (ELEV) 10-Day exponential moving average is 0.65, while Elevation Oncology’s (ELEV) share price is $0.65, making it a Sell.
Elevation Oncology’s (ELEV) 100-Day exponential moving average is 0.83, while Elevation Oncology’s (ELEV) share price is $0.65, making it a Sell.
Elevation Oncology’s (ELEV) stock price is $0.65 and Elevation Oncology’s (ELEV) 50-day simple moving average is 0.66, creating a Sell signal.
Elevation Oncology’s (ELEV) stock price is $0.65 and Elevation Oncology’s (ELEV) 100-day simple moving average is 0.62, creating a Buy signal.
Elevation Oncology’s (ELEV) stock price is $0.65 and Elevation Oncology’s (ELEV) 200-day simple moving average is 1.45, creating a Sell signal.

Elevation Oncology (ELEV) Technical Indicators

Feb 20, 2025, 11:52 PM
Name
Value
Implied Action
RSI (14)
49.47
Neutral
STOCH (9,6)
66.35
Neutral
STOCHRSI (14)
53.93
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
28.70
Neutral
Williams %R
-56.69
Buy
CCI (14)
25.98
Neutral
ATR (14)
0.07
-
Ultimate Oscillator
51.05
Neutral
ROC
4.84
Buy
Elevation Oncology’s (ELEV) Relative Strength Index (RSI) is 49.47, creating a Neutral signal.
Elevation Oncology’s (ELEV) Trend Strength Indicator (ADX) is 28.70, creating a Neutral signal.
Elevation Oncology’s (ELEV) Commodity Channel Index (CCI) is 25.98, creating a Neutral signal.
Elevation Oncology’s (ELEV) Price Rate of Change (ROC) is 4.84, creating a Buy signal.

FAQ

Is ELEV a Buy, Hold, or Sell?
Based on ELEV’s technical indicators, ELEV is a Sell.
    What is ELEV’s RSI (14)?
    ELEV’s RSI (14) is 49.47, which suggests ELEV is a Neutral.
      What is ELEV’s MACD?
      ELEV’s MACD is >-0.01, which suggests ELEV is a Sell.
        What is ELEV’s 5-day moving average?
        ELEV’s 5-day moving average is 0.66, which suggests ELEV is a Sell.
          What is ELEV’s 20-day moving average?
          ELEV 20-day moving average is 0.65, which suggests ELEV is a Buy.
            What is ELEV’s 50-day moving average?
            ELEV’s 50-day moving average is 0.66, which suggests ELEV is a Sell.
              What is ELEV’s 200-day moving average?
              ELEV’s 200-day moving average is 1.45, which suggests ELEV is a Sell.
                What is ELEV’s Williams % R (14)?
                ELEV’s Williams % R (14) is -56.69, which suggests ELEV is a Buy.
                  What is ELEV’s CCI (14)?
                  ELEV’s CCI (14) is 25.98, which suggests ELEV is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis